
Ep97: John Evans on Base Edited Therapeutics
The Long Run with Luke Timmerman
00:00
Selgine Deal - Why It Was So Important?
Agios was going after cancer metabolism. So this was finding new targets, and then we were going to drug them from scratch. And i think if we hadn't been able to do that kind of a selgine deal, where that amount of capital came in early, we would have just had to be much more narrow in our focus. You knowyou take two or three targets and you develop some drugs, and you hope for the best. But with the sel gine deal, and it was great that they shared this vision, we suddenly had the capital go after a much bigger pool of targets"
Transcript
Play full episode